1. Chi, Jiangyang, Zhang, Hongyan, Hu, Jia, Wang, Lin, Wang, Zheng. 2019. AGR3 promotes the stemness of colorectal cancer via modulating Wnt/β-catenin signalling. In Cellular signalling, 65, 109419. doi:10.1016/j.cellsig.2019.109419. https://pubmed.ncbi.nlm.nih.gov/31526829/
2. Jian, Lei, Xie, Jian, Guo, Shipeng, Li, Kang, Liu, Shengchun. 2020. AGR3 promotes estrogen receptor-positive breast cancer cell proliferation in an estrogen-dependent manner. In Oncology letters, 20, 1441-1451. doi:10.3892/ol.2020.11683. https://pubmed.ncbi.nlm.nih.gov/32724387/
3. King, Erin R, Tung, Celestine S, Tsang, Yvonne T M, Gershenson, David M, Wong, Kwong-Kwok. . The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer. In The American journal of surgical pathology, 35, 904-12. doi:10.1097/PAS.0b013e318212ae22. https://pubmed.ncbi.nlm.nih.gov/21451362/
4. de Moraes, Carolina Leão, Cruz E Melo, Natália, Valoyes, Maira Andrea Valoyes, Naves do Amaral, Waldemar. 2021. AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer. In Clinical breast cancer, 22, e242-e252. doi:10.1016/j.clbc.2021.07.008. https://pubmed.ncbi.nlm.nih.gov/34462207/
5. Garczyk, Stefan, von Stillfried, Saskia, Antonopoulos, Wiebke, Rose, Michael, Dahl, Edgar. 2015. AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection. In PloS one, 10, e0122106. doi:10.1371/journal.pone.0122106. https://pubmed.ncbi.nlm.nih.gov/25875093/
6. Gray, Terry A, MacLaine, Nicola J, Michie, Caroline O, Gourley, Charlie, Hupp, Ted R. 2012. Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models. In Journal of immunological methods, 378, 20-32. doi:10.1016/j.jim.2012.01.013. https://pubmed.ncbi.nlm.nih.gov/22361111/
智鼠故事 
